GLP-1 Weight Loss11 min read·Published July 16, 2026

How to Get Weight-Loss Injections Online: A Patient’s Guide to GLP-1 Telehealth

What to expect, who may qualify, what it can cost, and how to tell if an online GLP-1 provider is legitimate.

ByDr. Marcus Holloway
Clinically reviewed by Dr. Anika Rao
How to Get Weight-Loss Injections Online: A Patient’s Guide to GLP-1 Telehealth

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

You can get weight-loss injections online through licensed telehealth providers that prescribe GLP-1 medications like semaglutide and tirzepatide, including compounded versions from 503A pharmacies. A U.S.-licensed clinician reviews your BMI, medical history, and safety risks, then sends an appropriate prescription to a pharmacy for home delivery.

Can you actually get weight-loss injections online?

Yes. Weight-loss injections can be prescribed through telehealth when a licensed clinician evaluates you and decides a prescription is appropriate; they cannot be legally sold as prescription drugs without that step [10]. The online visit usually replaces an in-person visit, but it does not replace medical judgment, safety screening, or follow-up.

The main online options are FDA-approved injectable medications, such as Wegovy, Zepbound, and Saxenda for chronic weight management, and compounded semaglutide or compounded tirzepatide when prepared for an individual patient by a state-licensed 503A pharmacy under a valid prescription [1][2][3][9]. Compounded GLP-1s are not FDA-approved products, and their quality depends on the prescriber, pharmacy, ingredients, and testing standards [9].

It is not the same as “buying shots online.” A legitimate service verifies your identity, reviews your health history, checks for contraindications, explains side effects, and uses a licensed pharmacy [10]. Side effects and risks matter because GLP-1 medicines can cause gastrointestinal symptoms and carry warnings for pancreatitis, gallbladder disease, kidney injury from dehydration, and thyroid C-cell tumor risk on relevant labels [1][2][3].

Which weight-loss injections can be prescribed online?

A clinician may prescribe semaglutide, tirzepatide, or liraglutide online if the medication fits your health profile and state rules. The FDA-approved weight-management labels use long-term treatment language, but possible benefits must be weighed against side effects, contraindications, cost, and follow-up needs [1][2][3].

Medication optionDrug classFDA status for weight managementCommon online access routeKey safety notes
Wegovy (semaglutide)GLP-1 receptor agonistFDA-approved for chronic weight management in eligible adults and some adolescents; also has a cardiovascular risk-reduction indication in certain adults with obesity or overweight and established cardiovascular disease [1]Telehealth prescription to a retail, mail-order, or partner pharmacyNausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder warnings, pancreatitis warning, and contraindication with personal or family history of medullary thyroid carcinoma or MEN 2 [1]
Ozempic (semaglutide)GLP-1 receptor agonistFDA-approved for type 2 diabetes and certain cardiovascular and kidney-related risk indications, not FDA-approved as a weight-loss drug [4]May be prescribed online for FDA-approved diabetes indications when clinically appropriateSimilar GLP-1 class warnings; weight-loss-only use is off-label and should be discussed neutrally with a clinician [4]
Zepbound (tirzepatide)GIP/GLP-1 dual agonistFDA-approved for chronic weight management in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity [2]Telehealth prescription to a retail, mail-order, or partner pharmacyNausea, diarrhea, vomiting, constipation, abdominal pain, pancreatitis warning, gallbladder warnings, and contraindication with personal or family history of medullary thyroid carcinoma or MEN 2 [2]
Mounjaro (tirzepatide)GIP/GLP-1 dual agonistFDA-approved for type 2 diabetes, not FDA-approved as a weight-loss drug [5]May be prescribed online for diabetes when clinically appropriateWeight change can occur in diabetes trials, but weight-loss-only use is off-label and requires clinician review [5]
Saxenda (liraglutide)GLP-1 receptor agonistFDA-approved for chronic weight management in eligible adults and some adolescents [3]Telehealth prescription to a pharmacyDaily injection; side effects include nausea, vomiting, diarrhea, constipation, and warnings similar to GLP-1 class labeling [3]
Compounded semaglutide or compounded tirzepatide via 503A pharmacyCompounded GLP-1 or GIP/GLP-1 medicationNot FDA-approved products; compounded for an individual patient under prescription [9]Telehealth prescription sent to a state-licensed 503A compounding pharmacyQuality, formulation, and testing vary; FDA has warned patients about unapproved GLP-1 products and dosing errors with compounded injectable products [9][11]

Semaglutide (Wegovy, Ozempic)

Wegovy (semaglutide, a GLP-1 receptor agonist; also available as compounded semaglutide through licensed 503A pharmacies when prescribed for an individual patient) is FDA-approved for chronic weight management in eligible patients [1]. The FDA-approved starting dose for Wegovy is 0.25 mg once weekly for the first 4 weeks, with label-directed titration to maintenance doses used in clinical care [1].

In the STEP 1 trial, adults without diabetes who received semaglutide 2.4 mg once weekly plus lifestyle intervention had greater average weight loss than those who received placebo plus lifestyle intervention, but individual results varied and gastrointestinal side effects were common [6]. Ozempic is also semaglutide, but it is FDA-approved for type 2 diabetes-related indications, not as a weight-loss medication [4].

Tirzepatide (Zepbound, Mounjaro)

Zepbound (tirzepatide, a GIP/GLP-1 dual agonist; also available as compounded tirzepatide through licensed 503A pharmacies when prescribed for an individual patient) is FDA-approved for chronic weight management in eligible adults [2]. The Zepbound label describes once-weekly injections and dose escalation under clinician supervision [2].

In the SURMOUNT-1 trial, adults with obesity or overweight without diabetes who received tirzepatide 5 mg, 10 mg, or 15 mg once weekly plus lifestyle intervention had greater average weight reduction than placebo, but individual results varied and gastrointestinal side effects were frequent [7]. Mounjaro is also tirzepatide, but it is FDA-approved for type 2 diabetes, not as a weight-loss drug [5].

Liraglutide (Saxenda)

Saxenda (liraglutide, a GLP-1 receptor agonist) is FDA-approved for chronic weight management in eligible adults and some adolescents [3]. Unlike semaglutide and tirzepatide weight-management products, Saxenda is injected once daily according to its FDA label [3].

In a large randomized trial, participants receiving liraglutide 3.0 mg daily plus lifestyle counseling had greater average weight loss than participants receiving placebo plus lifestyle counseling, but individual results varied and nausea, vomiting, and diarrhea were more common with liraglutide [8].

Compounded semaglutide and tirzepatide via 503A pharmacies

Compounded semaglutide and compounded tirzepatide are not FDA-approved products. They may be prepared by a state-licensed 503A pharmacy for an individual patient after a licensed clinician writes a prescription, but FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed [9].

The FDA has warned about dosing errors and adverse events with compounded injectable semaglutide products, especially when patients must measure doses from vials rather than using a prefilled pen [11]. If a clinician discusses compounded options, ask which pharmacy is used, whether the pharmacy is licensed, what form of the active ingredient is used, and whether potency and sterility testing are performed [9][11].

Who qualifies for weight-loss injections through telehealth?

Many FDA-approved weight-management injection labels use BMI 30 or higher, or BMI 27 or higher with at least one weight-related condition, as core adult eligibility criteria [1][2][3]. A clinician still has to decide whether possible benefits outweigh risks for your specific health history.

BMI thresholds: 30+, or 27+ with a weight-related condition

Body mass index, or BMI, is a height-and-weight screening tool. Wegovy, Zepbound, and Saxenda labels include adult use in people with obesity, or overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol [1][2][3].

BMI does not tell the whole story. A telehealth clinician may also ask about waist size, weight history, prior treatments, pregnancy plans, mental health history, eating disorder history, diabetes status, kidney or gallbladder problems, and other medicines [1][2][3].

Who should not use GLP-1s

GLP-1 medicines are not right for everyone. Wegovy, Zepbound, and Saxenda labels include a boxed warning about thyroid C-cell tumors and list contraindications for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1][2][3].

A clinician may be cautious or avoid treatment if you are pregnant, planning pregnancy, breastfeeding, have a history of pancreatitis, have severe gastrointestinal disease, have certain gallbladder problems, or take medications that may interact or raise safety concerns [1][2][3]. Side effects such as nausea, vomiting, diarrhea, constipation, and dehydration-related kidney problems are part of the safety review, not an afterthought [1][2][3].

How does the online process work, step by step?

A legitimate online process has 3 basic steps: intake, clinician review, and pharmacy fulfillment with follow-up. The details vary by state and provider, but prescription rules and safety screening still apply [10].

  1. 1Complete an intake form with your height, weight, medical history, current medications, allergies, pregnancy status, and weight-related conditions.
  2. 2Verify your identity and state of residence so the service can match you with a clinician licensed where you live.
  3. 3A clinician reviews your information and may request labs, records, or a video or phone visit before deciding whether a prescription is appropriate.
  4. 4If prescribed, the medication is sent to a licensed pharmacy, such as a retail pharmacy, mail-order pharmacy, or 503A compounding pharmacy for eligible compounded prescriptions.
  5. 5You receive counseling on side effects, when to seek care, storage, injection training, and follow-up timing.

Intake questionnaire and ID verification

The intake is not busywork. It helps the clinician check label criteria, contraindications, and risks such as pancreatitis warning signs, gallbladder disease, kidney problems from dehydration, and thyroid tumor history [1][2][3].

Clinician review and prescription

A prescription should come from a licensed clinician, not from an online store. The FDA warns that prescription medicines bought outside the regulated supply chain may be unsafe, counterfeit, contaminated, or the wrong strength [10].

Delivery and follow-up

After approval, the pharmacy dispenses the medication and ships it when home delivery is available. Follow-up matters because side effects are common early in treatment, and clinicians may adjust care, pause therapy, or evaluate symptoms such as severe abdominal pain, persistent vomiting, dehydration, or signs of gallbladder disease [1][2][3].

How much do weight-loss injections cost online?

Online weight-loss injections can cost from a copay to more than $1,000 per month for some brand-name prescriptions without coverage, depending on insurance, pharmacy, savings programs, and the product [12][13]. Prices, availability, and shortage status change often, so verify the current price before you pay.

Brand-name pricing with and without insurance

Brand-name Wegovy, Zepbound, and Saxenda are FDA-approved products, but coverage varies by plan and employer benefit design [1][2][3]. Some people pay a standard pharmacy copay, while others face the cash price if their plan excludes weight-management drugs.

Manufacturer savings programs

Manufacturer programs can lower out-of-pocket costs for eligible patients, but terms can change and usually depend on insurance type. NovoCare provides Wegovy savings and coverage tools, and Lilly provides Zepbound access and savings resources through LillyDirect and related programs [12][13].

Compounded GLP-1 cash pricing

Compounded GLP-1 cash pricing is often presented as a monthly program fee, medication fee, or bundled telehealth plan. Compounded semaglutide and compounded tirzepatide are not FDA-approved products, and a lower cash price should still come with clinician review, prescription oversight, pharmacy licensing, and clear safety counseling [9][11].

How do I get weight-loss injections online through Chia?

If you are comparing licensed telehealth options, Chia offers a clinician-reviewed path for eligible adults to discuss compounded GLP-1 options, including prescriptions filled through U.S. 503A pharmacy partners when appropriate. Compounded GLP-1s are not FDA-approved products, so a licensed clinician must review eligibility, contraindications, side effects, and FDA-approved alternatives before prescribing [9][11].

A careful online provider should explain both possible benefits and trade-offs. GLP-1 and GIP/GLP-1 medicines have shown average weight-loss effects in eligible clinical-trial populations, but side effects are common, not everyone responds the same way, and some people should not use these medicines because of label contraindications or medical history [1][2][6][7].

3-min quiz

Considering an online GLP-1 evaluation?

A licensed clinician can review your BMI, health history, medications, and safety risks to see whether a prescription option is appropriate.

Are online weight-loss injections safe and legit?

Online weight-loss injections can be legitimate when they come from a licensed clinician and licensed pharmacy. Be careful: no-prescription GLP-1 sales are a major red flag, and the FDA warns that medicines bought from unsafe online sources may be counterfeit, contaminated, expired, or the wrong strength [10].

What to look for in a legitimate telehealth provider

  • A licensed clinician reviews your health history before prescribing.
  • The service verifies your identity and state of residence.
  • The pharmacy is named and licensed in the United States.
  • The provider explains FDA status, including whether a medication is FDA-approved or compounded.
  • You receive side-effect counseling, injection guidance, and clear follow-up instructions.
  • The provider gives realistic expectations and does not promise a specific number of pounds lost.
  • The service has a way to contact a clinician if side effects occur.

Red flags to avoid

  • A website sells prescription injections without a prescription or clinician review.
  • The product is labeled only as “research use,” “not for human use,” or “peptide” while being marketed for weight loss.
  • The seller will not name the pharmacy or manufacturer.
  • The service promises guaranteed weight loss or uses before-and-after claims.
  • The dose is presented as a one-size-fits-all protocol rather than a clinician-managed prescription.
  • The product uses semaglutide salt forms or unclear ingredients instead of a transparent pharmacy label.
  • There is no plan for side effects, follow-up, or missed doses.

Safety is not only about whether the medicine has evidence for weight management. It is also about whether it is the right medicine for you, whether you understand side effects, and whether the supply chain is legal and traceable [1][2][3][9][10].

What side effects can happen in your first month?

The most common early side effects are usually stomach-related. With GLP-1 medicines, nausea, vomiting, diarrhea, constipation, and abdominal pain are common label-listed adverse reactions, especially during dose escalation periods studied in trials and described in FDA labeling [1][2][3].

Some symptoms need urgent medical attention. Labels warn about pancreatitis symptoms such as severe abdominal pain that may radiate to the back, gallbladder problems, dehydration-related kidney injury, serious allergic reactions, increased heart rate for some products, and suicidal behavior or ideation monitoring in certain weight-management labels [1][2][3].

The first month is also when habits and follow-up matter. A clinician may review hydration, constipation prevention, meal size, protein intake, injection technique, and whether symptoms are mild, persistent, or severe enough to change the plan [1][2][3].

Frequently asked questions

3-min quiz

Talk with a licensed clinician

If you are considering online weight-loss injections, start with a medical review that covers eligibility, contraindications, side effects, cost, and pharmacy options.

References

  1. 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information, 2024.
  2. 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information, 2024.
  3. 3.U.S. Food and Drug Administration. Saxenda (liraglutide) injection prescribing information, 2023.
  4. 4.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information, 2025.
  5. 5.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information, 2024.
  6. 6.Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
  7. 7.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
  8. 8.Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 2015.
  9. 9.U.S. Food and Drug Administration. Compounding and the FDA: questions and answers, 2024.
  10. 10.U.S. Food and Drug Administration. BeSafeRx: your source for online pharmacy information, 2024.
  11. 11.U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, 2024.
  12. 12.Novo Nordisk. NovoCare Wegovy savings and support resources, accessed 2026.
  13. 13.Eli Lilly and Company. LillyDirect and Zepbound savings resources, accessed 2026.

About this article

Dr. Marcus HollowayInternal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides